immatics biotechnologies GmbH Financial Flexibility Index
immatics biotechnologies GmbH financial flexibility index. immatics biotechnologies GmbH (4A3) has a Financial Flexibility Index of -0.69x as of June 2026. Free cash flow of €-59.59 Million (operating CF €-60.46 Million minus capex €871.00K) represents -1% of total liabilities (€86.11 Million). See immatics biotechnologies GmbH (4A3) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of immatics biotechnologies GmbH (2019–2025)
Financial flexibility index of immatics biotechnologies GmbH from 2019 to 2025. Historical Financial Flexibility Index trend for immatics biotechnologies GmbH across 7 annual periods. Check immatics biotechnologies GmbH earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
immatics biotechnologies GmbH Financial Flexibility Index by Year (2019–2025)
immatics biotechnologies GmbH financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for immatics biotechnologies GmbH. For the full cash flow conversion analysis, see immatics biotechnologies GmbH (4A3) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.17x | €-169.82 Million | €-176.63 Million | €78.24 Million | ▼ -86.0% |
| 2024 | -1.17x | €-141.55 Million | €-158.03 Million | €121.30 Million | ▼ -775.9% |
| 2023 | 0.17x | €49.19 Million | €18.23 Million | €284.88 Million | ▼ -68.3% |
| 2022 | 0.54x | €105.87 Million | €100.13 Million | €194.66 Million | ▼ -22.2% |
| 2021 | 0.70x | €105.24 Million | €100.13 Million | €150.58 Million | ▼ -2.3% |
| 2020 | 0.72x | €107.55 Million | €100.13 Million | €150.39 Million | ▲ +71.3% |
| 2019 | 0.42x | €73.11 Million | €70.97 Million | €175.11 Million | — |